BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36245969)

  • 21. Involvement of MicroRNA-1-FAM83A Axis Dysfunction in the Growth and Motility of Lung Cancer Cells.
    Liu PJ; Chen YH; Tsai KW; Yeah HY; Yeh CY; Tu YT; Yang CY
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33266425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma.
    Hu HB; Yang XP; Zhou PX; Yang XA; Yin B
    Genes Genomics; 2020 Feb; 42(2):179-188. PubMed ID: 31768767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An
    Han Y; Wong FC; Wang D; Kahlert C
    Cancer Inform; 2022; 21():11769351221100727. PubMed ID: 35645555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel epithelial-mesenchymal transition (EMT)-related gene signature of predictive value for the survival outcomes in lung adenocarcinoma.
    Cui Y; Wang X; Zhang L; Liu W; Ning J; Gu R; Cui Y; Cai L; Xing Y
    Front Oncol; 2022; 12():974614. PubMed ID: 36185284
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Wei S; Shao J; Wang J; Zhao T; Liu J; Shen X; Wang Y; Chen H; Wang G
    J Thorac Dis; 2022 Jul; 14(7):2652-2664. PubMed ID: 35928621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
    BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of ERCC6L correlates with poor prognosis and confers malignant phenotypes of lung adenocarcinoma.
    Huang X; Jiang L; Lu S; Yuan M; Lin H; Li B; Wen Z; Zhong Y
    Oncol Rep; 2022 Jul; 48(1):. PubMed ID: 35656882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of glycolysis-related
    Yu H; Yu Z; Qin C; Bian T; Shi M
    J Thorac Dis; 2022 Sep; 14(9):3488-3499. PubMed ID: 36245582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic Analysis of Expression Profiles and Prognostic Significance for
    Gan J; Li Y; Meng Q
    Front Mol Biosci; 2020; 7():572406. PubMed ID: 33363204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated analysis reveals critical cisplatin-resistance regulators E2F7 contributed to tumor progression and metastasis in lung adenocarcinoma.
    Mao X; Xu S; Wang H; Xiao P; Li S; Wu J; Sun J; Jin C; Shen M; Shi Y; Tang B; Yang Y; Chen W; Xu Z; Xu Y
    Cancer Cell Int; 2024 May; 24(1):173. PubMed ID: 38760774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High KIF2A expression promotes proliferation, migration and predicts poor prognosis in lung adenocarcinoma.
    Xie T; Li X; Ye F; Lu C; Huang H; Wang F; Cao X; Zhong C
    Biochem Biophys Res Commun; 2018 Feb; 497(1):65-72. PubMed ID: 29427669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma.
    Liu C; Peng X; Li Y; Liu S; Hou R; Zhang Y; Zuo S; Liu Z; Luo R; Li L; Fang W
    Biomed Pharmacother; 2020 Mar; 123():109780. PubMed ID: 31901550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FAM83A as a Potential Biological Marker Is Regulated by miR-206 to Promote Cervical Cancer Progression Through PI3K/AKT/mTOR Pathway.
    Rong L; Li H; Li Z; Ouyang J; Ma Y; Song F; Chen Y
    Front Med (Lausanne); 2020; 7():608441. PubMed ID: 33344485
    [No Abstract]   [Full Text] [Related]  

  • 34. DDIT4 overexpression associates with poor prognosis in lung adenocarcinoma.
    Song L; Chen Z; Zhang M; Zhang M; Lu X; Li C; Miao L
    J Cancer; 2021; 12(21):6422-6428. PubMed ID: 34659532
    [No Abstract]   [Full Text] [Related]  

  • 35. METTL7B (methyltransferase-like 7B) identification as a novel biomarker for lung adenocarcinoma.
    Ali J; Liu W; Duan W; Liu C; Song J; Ali S; Li E; Wang Q
    Ann Transl Med; 2020 Sep; 8(18):1130. PubMed ID: 33240979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SPP1 facilitates cell migration and invasion by targeting COL11A1 in lung adenocarcinoma.
    Yi X; Luo L; Zhu Y; Deng H; Liao H; Shen Y; Zheng Y
    Cancer Cell Int; 2022 Oct; 22(1):324. PubMed ID: 36266702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of KIF20A confers malignant phenotype of lung adenocarcinoma by promoting cell proliferation and inhibiting apoptosis.
    Zhao X; Zhou LL; Li X; Ni J; Chen P; Ma R; Wu J; Feng J
    Cancer Med; 2018 Sep; 7(9):4678-4689. PubMed ID: 30105795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of PELP1 in Lung Adenocarcinoma Promoted E
    Zhang D; Dai J; Pan Y; Wang X; Qiao J; Sasano H; Zhao B; McNamara KM; Guan X; Liu L; Zhang Y; Chan MSM; Cao S; Liu M; Song S; Wang L
    Pathol Oncol Res; 2021; 27():582443. PubMed ID: 34257530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CENPH overexpression promotes the progression, cisplatin resistance, and poor prognosis of lung adenocarcinoma via the AKT and ERK/P38 pathways.
    Li Q; Huang X; Li QY; Tang Y; Liang LB; Luo Q; Gong M; Song YX; Guo Q; Chen C
    Am J Cancer Res; 2023; 13(5):1682-1697. PubMed ID: 37293159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction of a prognostic risk assessment model for lung adenocarcinoma based on Integrin β family-related genes.
    Wu Y; Fu L; Wang B; Li Z; Wei D; Wang H; Zhang C; Ma Z; Zhu T; Yu G
    J Clin Lab Anal; 2022 Jun; 36(6):e24419. PubMed ID: 35403268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.